<DOC>
	<DOCNO>NCT00714974</DOCNO>
	<brief_summary>This prospective , randomize , blind study patient enrol either treat ( BIS group ) untreated ( non-BIS ) group employ bispectral analysis measure level sedation/analgesia patient receive neuromuscular block agent . To collect pertinent data critically ill patient receive NMBA 's . In particular correlate sedation/analgesic medication need group whose medication use determine value obtain bispectral analysis group medication deliver standard care presently use intensive care unit treat . To document patient monitor bispectral analysis able achieve appropriate level consciousness shorter time require less manipulation amount sedative analgesic medication monitor .</brief_summary>
	<brief_title>A Prospective , Randomized , Blinded Study BIS Analysis ICU Patients Requiring Neuromuscular Blocking Agents</brief_title>
	<detailed_description>This prospective , randomize blind study do order help evaluate level consciousness bispectral analysis ( BIS ) ICU patient pharmacologically paralyzed NMBAs ( neuromuscular blockade agent ) assess thing amount time require achieve appropriate level sedation/analgesia . Data collect evaluated via FDA approve equipment . The intent project evaluate technology require `` anesthesia '' like state ( use NMBAs ) prolong period critically ill patient population .</detailed_description>
	<mesh_term>Neuromuscular Blocking Agents</mesh_term>
	<criteria>Consented ICU patient , receive neuromuscular block agent . Unable consent</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>July 2008</verification_date>
	<keyword>Neuromuscular blocking agent</keyword>
	<keyword>Bispectral analysis</keyword>
</DOC>